Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Uhhh...The stock went up the other day with a big market drop. This isn't dropping because of the over all market. This is dropping because people know the gains won't last and that is is a garbage stock. Sorta why this has gone from 8 cents to under 1 cent. Garbage is as garbage does.
But, as thinly traded as this is, it could possible close up in the green if the whales come during power hour and start gobbling up shares.
Btw, where are those whales?
AND....Regen's big pharma partner Oncofakeapharma is trading in the green.
Great call! Every $RGBP gap that has filled has gone up from there!
Charts never lie, especially with OTC stocks.
No one should be if they understood the history of the stock. This is to be expected. There really is nothing Koos has done to further the pipeline. Pre clinical trials are great but do not VALIDATE anything other than it gives a company the data needed to submit to the FDA for IND clearance assuming everything else is in place to submit for the IND.
Recall that Koos and his world famous cancer doc, Dr. Kesari, were unsuccessful in getting the IND for DCellVax because the pre-clinical data was lacking. Hence why the IND was never approved to start P1 trials.
I am going to bet that we'll see a similar issue with what he is doing now.
Btw, most of the gain from yesterday is gone.
That shouldn't be surprising to anyone. And I was wrong. I thought we'd see some gain today and the sell off tomorrow. Looks like most traders know not to hold onto this for more than a few trading hours.
And Koos could slim down, lift weights, and win Mr Olympia!
Easy peasy, lemon short squeezey!
In all seriousness, maybe Koos will give success after 25 years of abject failure.
To more down red days! Lol
Wow, even I am surprised this is on the red today. Many astute investors now realize that anything Koos puts out is hot garbage and good for a one day small pop.
This is absolutely pathetic. Smh.
Oh NO!!!! I WAS WRONG! THE PPS IS TANKING AT THE OPEN!!!
WHY IS NO ONE BUYING BUT SELLING?
WE NEED THOSE PuMp ARTICLES FROM PND OTC WEBSITES!
Some have missed some obvious problems with Koos
How's the FDA fast track coming along?
Where is that 66 million in revenue?
What about that pre clinical trial listed by that third party bogus website that even the CEO doesn't acknowledge are in existence (weird he wouldn't mention them at all)?
Has Dyo Bio ever gotten back to you? No one from Dyo has emailed me back after I emailed them. Sorta suspicious when the website no longer exists and the company’s phone number is disconnected.
Not even Koos will comment on it when asked.
Why hasn't Lilly pounced yet? The human patent has come and gone.
Why hasn't Oncopharma raised any money for Koos' IP?
Where is that CSO Koos said he was going to hire back in December?
Where is that White paper from Brian?
Where are the submissions to the FDA to get the INDs active again?
Where is total payoff to the other debt holders?
Why hasn't Koos communicated a single word to his shareholders since December?
Why can't the stock hold any of its gains?
Why all the misinformation pumping the stock?
I dreamt that RGBP CEO Koos robbed my piggy bank and used the money to buy lap dances and Tequila shots in TJ.
Volume was pretty light. I wonder if it will be 2 sells to 1 buy on Thursday as the hype machine will kick in and people will get duped into buying shares tomorrow thinking the per-clinical news is somehow big news (it isn't only by that it is amazing that Koos has money to pay for it so maybe he sold his kidney to pay for it or maybe his Bro Brian gave him a loan).
what is sad is that this only went up 14%. This type of news would have normally made the stock go up at least 50% but so many have been burned by this stock in the past that it can only muster a measly low teen pop.
The days of miracles run seem to be over.
Know what I mean, Vern?
Wait.. whut?
You can't!
Don't you know that $rgbp is about to sky rocket to $1 very soon .. As soon as Koos gets this to clinical trials and make all of us millions of dollars!
Koos is claiming this will be in clinical trials quickly. As quickly as hemax or dcellvax or tcellvax or nr2f6?
Oh ... The excitement!
Koos' had asked for the results to be fast tracked prior to the issuance of 5 billion more shares to the OS. His Bod, meaning himself, will most likely approve the increase.
Lol rofl pimpl
How far do you think today's gain is going to be erased? My prediction is by the end of next week.
And did Koos sell the remaining shares of onph to pay for these tests?
OMG OMG OMG HUGE HUGE HUGE NEWS! LIKE NO ONE EVER DOES PRE CLINICAL TESTING! IT IS WHY KOOS IS A GENIUS!
AND JUST LOOK AT HOW ALL THE PRIOR PRE CLINICAL TESTING THAT KOOS HAS DONE OVER THE YEARS HAS DONE TO BRING THAT BILLION DOLLAR PATENTS TO MARKET!
on a side note, today's news proves the other link about that preclinical testing you pointed to is as FAKE NEWS as FAKE NEWS can get.
but you already now misinformation is just that, misinformation!
Hey, why didn't Koos get Chemdiv to do the tests?
OH WAIT....Chemdiv doesn't want to do business with a dead beat.
I wonder if ProMab Biotechnologies, Inc had Koos pay in advance. I am sure they are well aware of what a dead beat he is in regard to paying his vendors.
People should email Promab and warn them who they are doing business with.
info@promab.com
I'll be sure to email ProMab Biotechnologies, Inc if they don't know who they are dealing with. I am sure they'll be interested in hearing about how Koos settled with Chemdiv and had to pay them $800K for work he refused to pay them on.
As suspected, some have missed the very glaring fact that said links are not backed up by the company or the CEO.
Hence, misinformation to the nth degree.
Because I can. Is there an issue with pointing out the misinformation being posted on here? To date, not one person can "honestly" dispute my points. Posting unrelated links to third party hype websites is not exactly being intellectually honest.
Some have missed some obvious problems with Koos
How's the FDA fast track coming along?
Where is that 66 million in revenue?
What about those pre clinical trials that even the CEO doesn't acknowledge are in existence (weird he wouldn't mention them at all)?
Has Dyo Bio ever gotten back to you? No one from Dyo has emailed me back after I emailed them. Sorta suspicious when the website no longer exists and the company’s phone number is disconnected.
Not even Koos will comment on it when asked.
Why hasn't Lilly pounced yet? The human patent has come and gone.
Why hasn't Oncopharma raised any money for Koos' IP?
Where is that CSO Koos said he was going to hire back in December?
Where is that White paper from Brian?
Where are the submissions to the FDA to get the INDs active again?
Where is total payoff to the other debt holders?
Why hasn't Koos communicated a single word to his shareholders since December?
Why can't the stock hold any of its gains?
Why all the misinformation pumping the stock?
Again, confusing patents with saving lives. There is zero evidence that anything regen has in its patents saves a life. As I said, wishful thinking.
The amount of wishful thinking will never help an incompetent ceo who uses lax otc rules to fund his lavish lifestyle of yachting and Italian sports cars. The evidence is clear with Koos.
Easier said than done. What is the success rate of biotechs? Less than 10%. Koos’ success rate over two decades? A big fat zero % and it will remain that way, in my expert opinion.
WRONG! As suspected, another big whopper! So much misinformation there.
Regen wasn't around in 2010. Koos started Regen when he was fleecing Biomatrix back in 2012. Failure begets failure!
https://www.biospace.com/article/releases/bio-matrix-scientific-group-inc-announces-newly-formed-stem-cell-subsidiary-b-regen-biopharma-inc-b-secures-20-000-000-in-institutional-fund/
Wrong! Not one red federal cent will go to Regen.
In fact, Koos won't be able to raise any non dilutive funding if he can raise any at all
You can take that to da bank!
I’m positive we’ll get an update on the buyout! Just after koos names his brother as the new CSO!
lol ROFL pimpl!
Was that the preclinical trial that Koos supposedly is doing in the bogus link that was posted?
NOPE! LOL
Looks like that uplisting was more bs from this bs company. Onco hasn’t done sheet, not unlike that other bogus company and onco’s partner in crime, regen.
Is it no wonder the stock price has totally cratered?
Some have missed some obvious problems with Koos
How's the FDA fast track coming along?
Where is that 66 million in revenue?
What about those pre clinical trials that even the CEO doesn't acknowledge are in existence (weird he wouldn't mention them at all)?
Has Dyo Bio ever gotten back to you? No one from Dyo has emailed me back after I emailed them. Sorta suspicious when the website no longer exists and the company’s phone number is disconnected.
Not even Koos will comment on it when asked.
Why hasn't Lilly pounced yet? The human patent has come and gone.
Why hasn't Oncopharma raised any money for Koos' IP?
Where is that CSO Koos said he was going to hire back in December?
Where is that White paper from Brian?
Where are the submissions to the FDA to get the INDs active again?
Where is total payoff to the other debt holders?
Why hasn't Koos communicated a single word to his shareholders since December?
Why can't the stock hold any of its gains?
Why all the misinformation pumping the stock?
Outstanding results? Lol!
What results are you actually hoping for from a company that has zero revenue generating products? Let me rephrase, a company that has absolutely no products and absolutely no revenue and absolutely no way to ever bring those products to market.
Some have missed some obvious problems with Koos
How's the FDA fast track coming along?
Where is that 66 million in revenue?
What about those pre clinical trials that even the CEO doesn't acknowledge are in existence (weird he wouldn't mention them at all)?
Has Dyo Bio ever gotten back to you? No one from Dyo has emailed me back after I emailed them. Sorta suspicious when the website no longer exists and the company’s phone number is disconnected.
Not even Koos will comment on it when asked.
Why hasn't Lilly pounced yet? The human patent has come and gone.
Why hasn't Oncopharma raised any money for Koos' IP?
Where is that CSO Koos said he was going to hire back in December?
Where is that White paper from Brian?
Where are the submissions to the FDA to get the INDs active again?
Where is total payoff to the other debt holders?
Why hasn't Koos communicated a single word to his shareholders since December?
Why can't the stock hold any of its gains?
Why all the misinformation pumping the stock?
As suspected, all of that is 100% misinformation.
Some have missed some obvious problems with Koos
How's the FDA fast track coming along?
Where is that 66 million in revenue?
What about those pre clinical trials that even the CEO doesn't acknowledge are in existence (weird he wouldn't mention them at all)?
Has Dyo Bio ever gotten back to you? No one has to me. Sorta suspicious when the website no longer exists and the company’s phone number is disconnected.
Not even Koos will comment on it when asked.
Why hasn't Lilly pounced yet? The human patent has come and gone.
Why hasn't Oncopharma raised any money for Koos' IP?
Where is that CSO Koos said he was going to hire back in December?
Where is that White paper from Brian?
Where are the submissions to the FDA to get the INDs active again?
Where is total payoff to the other debt holders?
Why hasn't Koos communicated a single word to his shareholders since December?
Why can't the stock hold any of its gains?
Why all the misinformation pumping the stock?
FACTS are stubborn things
Not like you didn't already know, but Koos and Regen have been and always will be royally plucked. Not only has Koos never been able to find any true funding to further the pipeline, the economy and biofunding spigots are shutting down. Notice how Konman Koos didn't get one RED CENT from any of that nor will he ever through legit means. He's a grade A loser and fraud. Naked shorters are more morally and ethically supreme than Koos.
From BioPharmGuy:
Monthly Funding Summary
In August we tracked $1.86B in funding at private companies plus two IPOs for $18M. The taps are definitely continuing to close.
The August funding summary, including company information, is available on our downloads page.
Do we know who those NOTES were to? Was it Koos? Is that how Koos is paying himself?
Where did that $66 million come from? The company surely doesn't have that in cash or any other asset. Is that REAL income or an accounting trick?
And if Koos had 66 million in earnings, why would he have to issue the toxic lender shares to pay off the loan?
Makes no sense unless you realize that income isn't income in the true sense but just an accounting trick.
Please give me the 411!
Oh nevermind, we all know it is accounting BS. The company has no money on hand.
And those remaining 18300 shares of onph Koos has are now worth $17,751.00
Ouch!!!!
what is even more sad is that deadbeat dave wasnt even able to get any of his bogus, fraudulent , dilution machine, scam otc companies off the ground even when the economy was roaring.
how is that for being incompetent?
Just remember folks, this has to fill the .0087s before it takes off…
Oh wait…
Lol rofl pimpl!,!!,!!,,!
Whoop! WHOOP! Attention Kmart shoppers: rgbp Blue light special on sale aisle 6. on sale for 0067.
That will happen when The konman Koos dilutes to death rgbp like he did with BMSN.
Is regen’s partner, onph, now a buy at 90 cents? What a fall that stock has taken